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ABSTRACT 
Metformin is widely used for the treatment of diabetes; the intention of the present study was to formulate Metformin HCl liposomes for a 
sustained drug delivery system. It have the advantages of dose reduction, less dosing frequency, minimize the side effect, prolong the action of 
drug and thus achieve better patient compliance. The liposomes were prepared by physical dispersion and ether injection method. Soya lecithin 
and cholesterol were used for encapsulating the drug, it facilitates to release the medicaments in sustained manner. Chloroform, ether and 
methanol were used as a solvent. Phosphate buffer pH 6.8 was used as a hydration medium for loading the drug. The final liposome was 
evaluated in various quality parameters of drug entrapment efficiency, morphological analysis, particle size analysis, in-vitro drug release studies 
and stability studies. In the two methods of metformin liposome formulation the ether injection method showed prolonged action when 
compared to physical dispersion method. In the parameters of drug entrapment and stability physical dispersion method was shows better 
results. 
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INTRODUCTION 
Novel Drug Delivery system (NDDS) is a combination of 
advance technique of dosage form which are far better than 
conventional dosage form1.The goal of NDDS is to provide a 
therapeutic amount of drug to the appropriate site in the 
body to accomplish promptly and then maintain the desired 
drug concentration2. NDDS is combining polymer science, 
pharmaceutics and molecular biology3.   
Liposomes are colloidal, vesicular structure composed of one 
or more bilayers surrounding an equal number of aqueous 
compartment4. Liposomes are small artificial vesicles of 
spherical shape that can be created from cholesterol and 
natural nontoxic phospholipids. Due to their size and 
hydrophobic and hydrophilic character (besides 
biocompatibility), liposomes are promising systems for drug 
delivery5. The sphere like shell encapsulated a liquid interior 
which contain substances such as peptides, protein, 
hormones, enzymes, antibiotics, anti-fungal and anti-cancer 
agents4. Liposome properties differ significantly with lipid 
composition, surface charge, size, and the method of 
preparation. Moreover, the choice of bilayer components 
determines the ‘rigidity’ or ‘fluidity’ and the charge of the 
bilayer. For instance, unsaturated phosphatidylcholine 
species from natural sources (egg or soybean 
phosphatidylcholine) give much more permeable and less 
stable bilayers, whereas the saturated phospholipids with 
long acyl chains (for example, dipalmitoylphosphatidyl 
choline) form a rigid, rather impermeable bilayer structure5.  
It has been exhibited that phospholipids impulsively form 
closed structures when they are hydrated in aqueous 
solutions. Such vesicles which have one or more 
phospholipid bilayer membranes can transport aqueous or 
lipid drugs, depending on the nature of those drugs. Because 
lipids are amphipathic (both hydrophobic and hydrophilic) 
in aqueous media, their thermodynamic phase properties 
and self-assembling characteristics influence entropically 
focused confiscation of their hydrophobic sections into 
spherical bilayers. Those layers are referred to as lamellae6. 
Liposomes particle sizes ranges from 30 nm to several 
micrometers. They consist of one or more lipid bilayers 
surrounding aqueous units, where the polar head groups are 
oriented in the pathway of the interior and exterior aqueous 
phases7.  
MATERIALS AND METHODS 
Metformin Hcl, Cholestral and Sodium hydroxide was 
obtained from Reachem laboratory chemicals, Chennai. 
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Chloroform and ether obtained from Rankem laboraties, 
Haryana. Soya lecithin received from the urban platter food 
co., Mumbai. Potassium di hydrogen phosphate purchased 
from Merck specialities pvt. Ltd, Mumbai. All other chemicals 
used were of analytical grade and were used without further 
purification.  
Methodology 
Preparation of standard curve of Metformin HCl using 
pH 6.8 phosphate buffer8: 
Accurately weighed 100 mg metformin HCl was dissolved in 
water and the volume was make up to 100 ml using distilled 
water in a volumetric flask to obtain a solution of 1000 
µg/ml. From the above solution 10 ml was pipetted out into 
a 100 ml volumetric flask and made up to 100 ml using 
phosphate buffer pH 6.8 to get a stock solution of 100 µg/ml. 
From this stock solution, aliquots of 0.2ml, 0.4ml, 0.6ml, 
0.8ml, 1.0ml, 1.2ml, 1.4ml, 1.6ml, 1.8 ml and 2.0ml were 
pipetted out into a series of 10 ml volumetric flask and made 
up to mark with phosphate buffer pH 6.8 to get a 
concentration in the range of 2 to 20 µg/ml. The absorbance 
of the resulting solution was then measured at 233 nm using 
UV Double beam spectrophotometer against phosphate 
buffer pH 6.8 as blank. The standard curve was obtained by 
plotting concentration (µg/ml) values in X- axis and 
absorbance values in Y – axis. 
Preformulation studies 
The objective of preformulation testing is to generate 
information useful to the formulation in developing stable 
and bioavailable dosage forms. The use of preformulation 
parameters maximizes the chances in formulating an 
acceptable, safe, efficacious and stable product9. 
a) Solubility 
Solubility of Metformin Hcl in water, methanol, phosphate 
buffer pH 6.8 was determined at room temperature with the 
help of magnetic stirrer. 
b) Melting Point 
Melting point determination was done by using melting 
point apparatus. Small amount of pure drug of Metformin 
HCl was taken in a capillary tube and it was kept in the 
melting point apparatus and the melting point was noted10. 
c) Compatibility (Drug – excipients interaction) 
studies: 
FT-IR spectra were taken for the dried samples using FT-IR 
8400S (Shimadzu, Japan) to determine the possible 
interactions between the drug and polymers. The plain drug, 
lecithin, cholesterol and combination of drug with 
cholesterol and lecithin in three different ratios (1:1, 1:2 and 
1:3) were taken and mixed with KBr. 
The samples were compressed to form a pellet using a 
hydraulic press.  The prepared pellets were transformed into 
disk. The disk was applied to the centre of the sample 
holding device and scanned from 4,500 to 400 cm-1 using 
FT-IR spectrophotometer11.  
Formulation of liposomes loaded with Metformin 
hydrochloride: 
The formulation of liposomes loaded with Metformin HCl 
was prepared by two different techniques namely, physical 
dispersion method and ether injection method. In both the 
techniques ratio of cholesterol was kept as same and the 
lecithin concentration was increased as 1:1, 1:2 and 1:3.  
Physical dispersion method: 
Liposomes were prepared by physical dispersion method 
using different ratio of soya lecithin and cholesterol was kept 
as constant. In this method the soya lecithin and cholesterol 
were dissolved in chloroform. Then it was spread over flat 
bottom conical flask and allowed to evaporate at room 
temperature for overnight without disturbing the solution 
for a formation of lipid film.  The drug was dissolved in 
phosphate buffer pH 6.8. It act as an aqueous medium. Then 
the aqueous medium was added to the lipid film for 
hydration. For this the flask was inclined to one side and 
aqueous medium was introduced down the side of flask and 
flask was slowly returned to upright orientation. Then the 
conical flask was kept on water bath and the temperature 
was maintained at 37± 2ºC for 2 hours for the completion of 
hydration. The conical flask was gently shaken until the lipid 
layer was removed from wall of conical flask and formation a 
liposomes suspension. Then the formed liposomes 
suspension was stored at 4ºC for one day for the maturation 
of liposomes. The prepared liposome suspension was 
centrifuged at 15,000 rpm for 20 mins. Then the precipitate 
was collected and diluted with distilled water for further 
studies12. Different batches of liposomes were prepared as 
per the general method described above and composition for 
the preparation of liposomes is given in Table No. 1. 
Ether injection method: 
Liposomes were prepared by ether injection method using 
different ratio of soya lecithin and cholesterol was kept as 
constant. In this method the cholesterol and soya lecithin 
were dissolved in ether and methanol. The drug was 
dissolved in phosphate buffer pH 6.8. It act as an aqueous 
medium. The aqueous medium was heated to 60°C. The 
method involves injecting drop by drop of ether-lipid 
solutions into the above warmed aqueous medium. The 
ether vaporizes upon contacting the aqueous phase, and the 
dispersed lipid forms primarily unilamellar liposomes. Then 
the product was collected and it was stored at 4°C for 
maturation of liposome. Then prepared liposomal 
suspension was centrifuged at 15,000 rpm for 20 mins. The 
precipitate was diluted with distilled water for evaluation 
studies13. Different batches of liposomes were prepared as 
per the general method described above and composition for 
the preparation of liposomes is given in Table No. 1. 
 
Table 1: Formulation of Metformin HCl liposomes 
S. No. Ingredients Physical dispersion method Ether injection method 
F 1 F 2 F 3 F 4 F 5 F 6 
1. Cholesterol 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 
2. Lecithin 100 mg 200 mg 300 mg 100 mg 200 mg 300 mg 
3. Metformin HCl 10 gm 10 gm 10 gm 10 gm 10 gm 10 gm 
4. Ether - - - 7 ml 7 ml 7 ml 
5. Methanol - - - 3 ml 3 ml 3 ml 
6 Chloroform 5 ml 5 ml 5 ml - - - 
7. Phosphate buffer pH 6.8 50 ml 50 ml 50 ml 50 ml 50 ml 50 ml 
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Evaluation of liposomes: 
1. Determination of percentage drug entrapment 
efficiency: 
Drug entrapment efficiency was calculated by using 
centrifugation method. 10 ml of liposome suspension was 
taken and centrifuged at 15,000 rpm for 20 mins. The 
supernatant liquid was collected and suitably diluted. Then 
the absorbance was taken at 233 nm with the help of UV 
double beam spectrophotometer using pH 6.8 as a blank. The 
drug entrapment efficiency was calculated from the 
following formula14. 
Total entrapment efficiency =  
                                     
              
  × 100 
2. Morphology analysis: 
The prepared Metformin HCl liposomes for all the 
formulations were viewed under for observing the vesicle 
formation and discreteness of dispersed vesicles. A slide was 
prepared by placing a drop of liposome dispersion on a glass 
slide and cover slip was placed over it and this slide was 
viewed under optical microscope at 40X magnification. 
Photographs were taken to prepared slides using digital 
camera15. 
3. In vitro drug release study: 
The in vitro release for all the formulated Metformin HCl 
liposomes were carried out for 8 hours in phosphate buffer 
pH 6.8. The studies were carried in USP dissolution 
apparatus II (Paddle) at 37ºC ± 0.5ºC and 50 rpm speed. 900 
ml of phosphate buffer pH 6.8 was used as a dissolution 
medium. Equivalent to 100 mg of Metformin HCl liposome 
was taken in a dissolution jar contains dissolution medium 
and the paddle was rotated at 50 rpm. 1 ml of samples were 
withdrawn at every 30 minutes up to 480 minutes and make 
up the sample to 10 ml with pH 6.8 buffer and analyzed for 
Metformin HCl content at 233 nm with pH 6.8 as blank using 
double beam UV double beam spectrophotometer16. 
4. Particle size determination: 
The particle size determination is done by using Shimadzu 
SALD – 2300 (WingSALD II: Version 3.1.1). Groups of 
particles are dispersed in a liquid medium and measured as 
they are circulated between the flow cell, which is placed in 
the measurement unit, and a dispersion bath in the sampler. 
The dispersion bath incorporates a stirrer and an ultrasonic 
sonicator. A pump delivers the dispersed suspension to the 
flow cell. The pump is specially designed to ensure both 
liquid medium and the particles are circulated. It can be 
controlled from a computer. Organic solvents can be used as 
dispersion media17. 
5. Stability studies: 
The behavior of the liposome to retain the drug was 
studied by storing the liposome at two different temperature 
conditions, i.e., 4ºC (refrigerator RF), 25°C±2ºC for a period 
of 1 month. The liposomal preparations were kept in sealed 
vials. At 30th day the samples were analyzed for the drug 
content following the same method described in % drug 
encapsulation efficiency and in vitro drug release. And also 
the liposomes were studied for their morphology18. 
RESULTS AND DISCUSSION 
Calibration of Metformin Hcl using phosphate buffer pH 
6.8: 
The Standard Calibration curves of metformin hydrochloride 
were prepared by using phosphate buffer pH 6.8 and 
absorbance were analyzed in 233nm. The correlation 
coefficient was found to be 0.9994. The results indicate 
Metformin hydrochloride obeys the beer’s law within the 
concentration range of (2-20µg/ml).  Calibration plot of 
metformin was shown in Table No. 2 and Figure 2. 
 
 Table 2: Calibration curve of Metformin 
Sl. No. Concentration  
(µg/ml) 
Absorbance  
at 233 nm 
1.  2 0.189 
2.  4 0.370 
3.  6 0.524 
4. - 8 0.699 
5.  10 0.858 
6.  12 1.055 
7.  14 1.244 
8.  16 1.394 
9.  18 1.568 
10.  20 1.716 Figure 1: Calibration curve of Metformin  
Preformulation studies 
a) Solubility 
The solubility of raw drug was determined by dissolving in 
distilled water, methanol and phosphate buffer pH 6.8. The 
drug was found to be freely soluble in water, soluble in 
methanol and phosphate buffer p H 6.8.  
b) Melting point 
It was found to be 224ºC which was within the specification 
range of standard. So it confirmed Metformin HCl present in 
raw material of drug. 
c) Compatibility (Drug – excipients) studies 
The FT – IR studies of pure Metformin HCl, cholesterol, soya 
lecithin and combination of Metformin HCl, cholesterol and 
soya lecithin were conduct to study the interaction between 
the drug and excipients. FT- IR spectral analysis showed that 
the fundamental peaks and patterns of the spectra were 
similar both in pure drug and combination containing drug 
and highest proportion of excipients. This indicated that 
there was no chemical interaction between Metformin HCl 
and the other excipients used in the formulations. The 
spectral data’s are presented in Table 3-6 and spectral 
peaks were presented graphically in Figure 2-5. 
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Figure 2: FT – IR of pure Metformin  
Table 3: FT – IR of pure Metformin 
Wave length (cm-1) Functional group 
3372 N-H stretching 
1582 Amino N-H bending 
1466 CH3 bending alkanes 
1057 C-N Stretching 
957 Alkene C-H bending 
 
 
Figure 3: FT – IR of cholesterol 
Table 4: FT – IR of cholesterol 
Wave length(cm-1) Functional group 
3421 N-H stretching 
1466  CH3 bending alkanes 
1057  C-N Stretching 
955  Alkene C-H bending 
 
 
Figure 4: FT – IR of  lecithin 
Table 5: FT – IR of lecithin  
Wave length  
(cm-1) 
Functional group 
3379 N-H stretching 
1620 Amino N-H bending 
1464 CH3 bending alkanes 
1104 C-N Stretching 
864 Alkene C-H bending 
 
 
Figure 8: IR of Metformin, cholesterol and  lecithin 
Table 7: FT – IR of combination of Metformin, 
cholesterol and  lecithin. 
Wave length 
(cm-1) 
Functional group 
3372 N-H stretching 
1582 Amino N-H bending 
1466 CH3 bending alkanes 
1057 C-N Stretching 
957 Alkene C-H bending 
 
 
 
 
 
 
 
 Subramanian et al                                                                                                       Journal of Drug Delivery & Therapeutics. 2019; 9(2):31-37 
ISSN: 2250-1177                                                                                  [35]                                                                                 CODEN (USA): JDDTAO 
Formulation of Metormin Hcl liposomes  
The Metformin liposome was prepared by physical 
dispersion method and ether injection method using Soya 
lecithin and cholesterol in different ratios as per formula 
designed in Table 1. The F1 to F3 formulation prepared by 
physical dispersion method, F4 to F6 formulation prepared 
by ether injection method.  
Evaluaton of Metormin HCl Liposomes 
Percentage drug entrapment efficiency 
The percentage drug entrapment efficiency of formulations F 
1, F 2 and F 3 were     86.60 %, 79.90 % and 73.10 % 
respectively and formulations F 4, F 5 and F 6 were 30.47%, 
39.58% and 39.69% respectively. The results may specify 
physical dispersion method have better drug entrapment 
efficiency than ether injection method. 
Morphology analysis 
The morphology characters of liposomes were analyzed by 
optical microscopy (Olympus Opto System, India) and the 
images were taken using digital camera. The formulation F 1 
- F 6 microscopic images were showed in Figure No. 6 -11. 
 
 
Figure 6: Microscopic image (45 
X) of  F 1 formulation 
 
Figure 7: Microscopic image (45 
X) of  F 2 formulation 
 
Figure 8: Microscopic image 
(45x) of  F 3 formulation 
 
 
Figure 9: Microscopic image(45x) 
of  F 4 formulation 
 
 
Figure 10: Microscopic image 
(45x) of  F 5 formulation 
 
 
Figure 11: Microscopic image 
(45x) of  F 6 formulation 
 
Particle size analysis 
The particle size analysis was carried out by malven particle 
size analyzer for all the prepared liposome formulations. The 
particle size for all the formulated liposomes were found be 
in the range of 30.617 µm to 0.031µm as shown in Table No. 
7. The particle size data showed that when the concentration 
of soya lecithin was increased the particle size was 
decreased invariably the Metformin HCl liposomes in 
prepared by both methods. The particle size of Metformin 
HCl liposomes of F 3 and F 6 were found to be lower when 
compared with other formulations this may be due to higher 
concentration of soya lecithin.  
Table 7: Particle size range 
Sl. No. Formulations Particle size range 
1.  F 1 30.617 – 1.563 µm 
2.  F 2 19.023 – 1.563 µm 
3.  F 3 0.071 -0.031µm 
4.  F 4 24.133 – 1.563 µm 
5.  F 5 0.081 – 0.031 µm 
6.  F 6 0.071 -0.031µm 
  
In vitro drug release studies 
The cumulative percentage drug release of formulations F 1, 
F 2 and F 3 were found to be 103.03±2.47, 91.92±2.72 and 
82.12±2.51 respectively in 8 hours.  The formulation F 1 
shows faster release than formulations F 2 and F 3 due to the 
lower concentration of soya lecithin. The cumulative 
percentage drug release of formulations F 4 was found to be 
100.58 ± 1.58 at the end of 7 hours. And the cumulative 
percentage drug release of formulations F 5 and F 6 were 
found to 85.06±1.73 and 81.39±1.12 respectively in 8 hours.  
The formulation F 4 show faster release than formulations F 
5 and F 6. While the concentration of soya lecithin was 
increasing it decrease the release of drug. 
The prepared liposomes F 1 to F 6 showed sustained release 
of drug. When increased ratios of soya lecithin also sustain 
the release of drug was increased in both methods of 
preparations. The Figure No. 12 and 13 shows the 
formulation F 1, F 2 and F 3 and F 4, F 5 and F 6 respectively 
in 8 hours. 
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Figure 12: Comparative cumulative percentage drug release of Metformin HCl liposome formulations of F 1, F 2 and F 3 
 
 
Figure 13: Comparative cumulative percentage drug release of Metformin HCl liposome formulations of F 4, F 5 and F 6 
 
Stability Studies 
All the formulations of Metformin HCl liposomes were 
relatively stable at 4ºC storage condition. The drug leakage 
percent amounts of original entrapped in liposomes were 
very small and the amount retained in vesicle had no 
significant difference after one month as compared to the 
amount immediately after preparation. But at the storage 
condition of 25°C±2°C, all the formulations of Metformin HCl 
liposomes were unstable. In addition, the result of drug 
entrapment studies showed higher leakage at higher 
temperature. This may be due the higher fluidity of lipid 
bilayer at higher temperature, resulting into higher drug 
leakage. The drug entrapment results were shown in table 
no. 8. 
 
Table 8: Stability study of percentage drug entrapment of Metformin HCl liposomes compared with percentage drug 
entrapment of immediately after preparation. 
Sl. No. 
Formulations 
code 
Immediately after 
preparation (%) 
After one month 
At 4°C At 25°C±2ºC 
1.  F 1 86.60 85.92% 76.87% 
2.  F 2 79.90 % 77.99% 70.98% 
3.  F 3 73.10 % 72.08% 66.89% 
4.  F 4 30.47% 29.35% 24.89% 
5.  F 5 39.58% 38.44% 35.39% 
6.  F 6 39.69% 38.36% 36.69% 
 
The morphological characters of Metformin HCl liposomes 
for F 1 – F 4 didn’t show any characteristic changes after it 
was stored at 4ºC and 25ºC±2ºC for a period of one month. F 
5 and F 6 formulations were showed slightly reduced in the 
size after it was stored at 25ºC±2ºC for a period of one 
month but there was no changes for the same formulation 
when it was stored at 4ºC. Microscopic images of all the 
formulations (F 1 – F 6) of Metformin HCl liposomes were 
compared with before and after stability studies. The results 
show there no significant changes.  
After one month, Metformin HCl liposomes formulations F 1 
to F 6 were showed difference in in vitro drug release profile. 
Dissolution rate was decreased in all Metformin HCl 
liposomes formulations at both storage conditions like 4°C 
and 25ºC±2ºC. The results of in vitro drug release of all the 
formulations at both storage conditions were compared with 
before and after stability studies and the results were shown 
in Table No. 9. 
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Table 9: In vitro drug release of Metformin liposome formulations after stability study, compared with before stability 
Sl. No. 
Formulation  
code 
Immediately after 
preparation 
After stability study 
At 4°C At 25ºC±2ºC 
1.  F 1 103.03±2.47 91.81 73.38 
2.  F 2 91.92±2.72 86.77 68.26 
3.  F 3 82.12±2.51 77.91 64.37 
4.  F 4 100.58±1.12 91.74 87.41 
5.  F 5 85.06±1.73 78.81 61.81 
6.  F 6 79.05±1.03 73.98 63.32 
  
 
At storage condition 4°C showed better stability than another 
condition. This may due to their elevated temperature reduce 
the stability. But in both storage conditions higher proportion 
of soya lecithin contains formulations like F 3 and F 6 showed 
better stability than other their formulations. 
SUMMARY AND CONCLUSION 
This study concluded that Metformin HCl was successfully 
prepared as a liposomal drug delivery system by using two 
different techniques such as physical dispersion method and 
ether injection method. The liposomes prepared by physical 
dispersion method showed better percentage drug 
entrapment when compared with ether injection method.  The 
morphological characters of prepared liposomes were 
determined with the help of optical microscope. The results of 
the particle size showed, when the concentration of soya 
lecithin was increased the size of the particle was reduced. 
The in vitro release showed that as the concentration of soya 
lecithin was increased the release rate of drug was retarded. 
Among the two methods ether injection method showed 
prolonged action when compared to physical dispersion 
method. The stability studies for all the formulations were 
performed by keeping the formulations at two different 
temperatures 4ºC±2ºC and 25ºC±2ºC for a period of 30 days. 
After the stability period the formulations were tested for 
morphological analysis, percentage drug entrapment and in 
vitro drug release and compared with before stability study. 
There was no change in morphological characters at 4ºC±2ºC, 
but there was a slight reduced in particles size at 25ºC±2ºC. 
The percentage drug entrapment was reduced in all the 
formulations at both the conditions. The in vitro drug release 
was reduced for all the formulations. Liposomes prepared by 
physical dispersion method showed better stability compared 
with ether injection method. 
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